|
1
|
Jiang SH, Tu WZ, Zou EM, Hu J, Wang S, Li
JR, Wang WS, He R, Cheng RD and Liao WJ: Neuroprotective effects of
different modalities of acupuncture on traumatic spinal cord injury
in rats. Evid Based Complement Alternat Med. 2014:4315802014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nardone R, Höller Y, Brigo F, Orioli A,
Tezzon F, Schwenker K, Christova M, Golaszewski S and Trinka E:
Descending motor pathways and cortical physiology after spinal cord
injury assessed by transcranial magnetic stimulation: a systematic
review. Brain Res. 139–154. 2014.PubMed/NCBI
|
|
3
|
Chen X, He F, Zhong DY and Luo ZP:
Acoustic-frequency vibratory stimulation regulates the balance
between osteogenesis and adipogenesis of human bone marrow-derived
mesenchymal stem cells. BioMed Res Int. 2015:5407312015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lin H, Luo X, Jin B, Shi H and Gong H: The
effect of EPO gene overexpression on proliferation and migration of
mouse bone marrow-derived mesenchymal stem cells. Cell Biochem
Biophys. Nov 14–2014.Epub ahead of print.
|
|
5
|
Munoz JL, Greco SJ, Patel SA, Sherman LS,
Bhatt S, Bhatt RS, Shrensel JA, Guan YZ, Xie G, Ye JH, et al:
Feline bone marrow-derived mesenchymal stromal cells (MSCs) show
similar phenotype and functions with regards to neuronal
differentiation as human MSCs. Differentiation. 84:214–222. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Song M, Jue SS, Cho YA and Kim EC:
Comparison of the effects of human dental pulp stem cells and human
bone marrow-derived mesenchymal stem cells on ischemic human
astrocytes in vitro. J Neurosci Res. 93:973–983. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tian L, Yin D, Ren Y, Gong C, Chen A and
Guo FJ: Plumbagin induces apoptosis via the p53 pathway and
generation of reactive oxygen species in human osteosarcoma cells.
Mol Med Rep. 5:126–132. 2012.
|
|
8
|
Luo P, Wong YF, Ge L, Zhang ZF, Liu Y, Liu
L and Zhou H: Anti-inflammatory and analgesic effect of plumbagin
through inhibition of nuclear factor-κB activation. J Pharmacol Exp
Ther. 335:735–742. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Subramaniya BR, Srinivasan G, Sadullah SS,
Davis N, Subhadara LB, Halagowder D and Sivasitambaram ND:
Apoptosis inducing effect of plumbagin on colonic cancer cells
depends on expression of COX-2. PLoS One. 6:e186952011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Erşahın M, Toklu HZ, Erzık C, Akakin D,
Tetık S, Sener G and Yeğen BC: Ghrelin alleviates spinal cord
injury in rats via its anti-inflammatory effects. Turk Neurosurg.
21:599–605. 2011.
|
|
11
|
Li F, Fei D, Sun L, Zhang S, Yuan Y, Zhang
L, Zhao K, Li R and Yu Y: Neuroprotective effect of bone marrow
stromal cell combination with atorvastatin in rat model of spinal
cord injury. Int J Clin Exp Med. 7:4967–4974. 2014.
|
|
12
|
Zhang W, Cheng L, Hou Y, Si M, Zhao YP and
Nie L: Plumbagin protects against spinal cord injury-induced
oxidative stress and inflammation in Wistar rats through Nrf-2
upregulation. Drug Res (Stuttg). 65:495–499. 2014. View Article : Google Scholar
|
|
13
|
Chio CC, Lin JW, Chang MW, Wang CC, Kuo
JR, Yang CZ and Chang CP: Therapeutic evaluation of etanercept in a
model of traumatic brain injury. J Neurochem. 115:921–929. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vink R, Young A, Bennett CJ, Hu X, Connor
CO, Cernak I and Nimmo AJ: Neuropeptide release influences brain
edema formation after diffuse traumatic brain injury. Acta
Neurochir Suppl. 86:257–260. 2003.
|
|
15
|
Wang T, Yuan W, Liu Y, Zhang Y, Wang Z,
Zhou X, Ning G, Zhang L, Yao L, Feng S and Kong X: The role of the
JAK-STAT pathway in neural stem cells, neural progenitor cells and
reactive astrocytes after spinal cord injury. Biomed Rep.
3:141–146. 2015.PubMed/NCBI
|
|
16
|
Chen MH, Ren QX, Yang WF, Chen XL, Lu C
and Sun J: Influences of HIF-lα on Bax/Bcl-2 and VEGF expressions
in rats with spinal cord injury. Int J Clin Exp Pathol.
6:2312–2322. 2013.
|
|
17
|
Bransford RJ, Chapman JR, Skelly AC and
Vanalstyne EM: What do we currently know about thoracic spinal cord
recovery and outcomes? A systematic review. J Neurosurg Spine.
17(Suppl 1): 52–64. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Adams M and Cavanagh JF: International
Campaign for Cures of Spinal Cord Injury Paralysis (ICCP): another
step forward for spinal cord injury research. Spinal Cord.
42:273–280. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mansilla E, Marin GH, Sturla F, Drago HE,
Gil MA, Salas E, Gardiner MC, Piccinelli G, Bossi S, Salas E, et
al: Human mesenchymal stem cells are tolerized by mice and improve
skin and spinal cord injuries. Transplant Proc. 37:292–294. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang L, Tu XH, Zhao P, Song JX and Zou ZD:
Protective effect of transplanted bone marrow-derived mesenchymal
stem cells on pancreatitis-associated lung injury in rats. Mol Med
Rep. 6:287–292. 2012.PubMed/NCBI
|
|
21
|
Qayumi AK, Janusz MT, Jamieson WR and
Lyster DM: Pharmacologic interventions for prevention of spinal
cord injury caused by aortic crossclamping. J Thorac Cardiovasc
Surg. 104:256–261. 1992.PubMed/NCBI
|
|
22
|
Cuevas P, Reimers D, Carceller F and
Jimenez A: Ischemic reperfusion injury in rabbit spinal cord:
protective effect of superoxide dismutase on neurological recovery
and spinal infarction. Acta Anat (Basel). 137:303–310. 1990.
View Article : Google Scholar
|
|
23
|
Koc RK, Akdemir H, Karakücük EI, Oktem IS
and Menkü A: Effect of methylprednisolone, tirilazad mesylate and
vitamin E on lipid peroxidation after experimental spinal cord
injury. Spinal Cord. 37:29–32. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang X, Chen C, Ma S, Wang Y, Zhang X and
Su X: Inhibition of monocyte chemoattractant peptide-1 decreases
secondary spinal cord injury. Mol Med Rep. 11:4262–4266.
2015.PubMed/NCBI
|
|
25
|
Yao AH, Jia LY, Zhang YK, Ma QR, Cheng P,
Liu L, Ju G and Kuang F: Early blockade of TLRs MyD88-dependent
pathway may reduce secondary spinal cord injury in the rats. Evid
Based Complement Alternat Med. 2012:5912982012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kadota R, Koda M, Kawabe J, Hashimoto M,
Nishio Y, Mannoji C, Miyashita T, Furuya T, Okawa A, Takahashi K
and Yamazaki M: Granulocyte colony-stimulating factor (G-CSF)
protects oligodendrocyte and promotes hindlimb functional recovery
after spinal cord injury in rats. PLoS One. 7:e503912012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tu XH, Song JX, Xue XJ, Guo XW, Ma YX,
Chen ZY, Zou ZD and Wang L: Role of bone marrow-derived mesenchymal
stem cells in a rat model of severe acute pancreatitis. World J
Gastroenterol. 18:2270–2279. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Checker R, Patwardhan RS, Sharma D, Menon
J, Thoh M, Sandur SK, Sainis KB and Poduval TB: Plumbagin, a
vitamin K3 analogue, abrogates lipopolysaccharide-induced oxidative
stress, inflammation and endotoxic shock via NF-κB suppression.
Inflammation. 37:542–554. 2014. View Article : Google Scholar
|
|
29
|
Benedict AL, Mountney A, Hurtado A, Bryan
KE, Schnaar RL, Dinkova-Kostova AT and Talalay P: Neuroprotective
effects of sulforaphane after contusive spinal cord injury. J
Neurotrauma. 29:2576–2586. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang X, de Rivero Vaccari JP, Wang H, Diaz
P, German R, Marcillo AE and Keane RW: Activation of the nuclear
factor E2-related factor 2/antioxidant response element pathway is
neuroprotective after spinal cord injury. J Neurotrauma.
29:936–945. 2012. View Article : Google Scholar :
|
|
31
|
Son TG, Camandola S, Arumugam TV, Cutler
RG, Telljohann RS, Mughal MR, Moore TA, Luo W, Yu QS, Johnson DA,
et al: Plumbagin, a novel Nrf2/ARE activator, protects against
cerebral ischemia. J Neurochem. 112:1316–1326. 2010. View Article : Google Scholar :
|
|
32
|
Cho KA, Woo SY, Seoh JY, Han HS and Ryu
KH: Mesenchymal stem cells restore CCl4-induced liver injury by an
antioxidative process. Cell Biol Int. 36:1267–1274. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu W, Zhang L, Shi J, Liu Y, Zhou L, Hou
K, Qu X and Teng Y: Clinical significance of pAkt and pErk1/2
expression in early-stage breast cancer patients treated with
anthracycline-based adjuvant chemotherapy. Oncol Lett. 9:1707–1714.
2015.PubMed/NCBI
|
|
34
|
Ha KS, Kim KM, Kwon YG, Bai SK, Nam WD,
Yoo YM, Kim PK, Chung HT, Billiar TR and Kim YM: Nitric oxide
prevents 6-hydroxydopamine-induced apoptosis in PC12 cells through
cGMP-dependent PI3 kinase/Akt activation. FASEB J. 17:1036–1047.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chuenkova MV and Pereiraperrin M:
Neurodegeneration and neuroregeneration in Chagas disease. Adv
Parasitol. 76:195–233. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen TL, Zhu GL, Wang JA, Wang Y, He XL
and Jiang J: Apoptosis of bone marrow mesenchymal stem cells caused
by hypoxia/reoxygenation via multiple pathways. Int J Clin Exp Med.
7:4686–4697. 2014.
|
|
37
|
Checker R, Sharma D, Sandur SK,
Subrahmanyam G, Krishnan S, Poduval TB and Sainis KB: Plumbagin
inhibits proliferative and inflammatory responses of T cells
independent of ROS generation but by modulating intracellular
thiols. J Cell Biochem. 110:1082–1093. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shin BA, Yoo HG, Kim HS, Kim MH, Hwang YS,
Chay KO, Lee KY, Ahn BW and Jung YD: p38 MAPK pathway is involved
in the urokinase plasminogen activator expression in human gastric
SNU-638 cells. Oncol Rep. 10:1467–1471. 2003.PubMed/NCBI
|
|
39
|
Galan-Arriero I, Avila-Martin G,
Ferrer-Donato A, Gomez-Soriano J, Bravo-Esteban E and Taylor J:
Oral administration of the p38α MAPK inhibitor, UR13870, inhibits
affective pain behavior after spinal cord injury. Pain.
155:2188–2198. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang T, Wu F, Jin Z, Zhai Z, Wang Y, Tu B,
Yan W and Tang T: Plumbagin inhibits LPS-induced inflammation
through the inactivation of the nuclear factor-kappa B and mitogen
activated protein kinase signaling pathways in RAW 264.7 cells.
Food Chem Toxicol. 64:177–183. 2014. View Article : Google Scholar
|
|
41
|
Wang Y, Wang J, Bai D, Song J, Ye R, Zhao
Z, Lei L, Hao J, Jiang C, Fang S, et al: Cell proliferation is
promoted by compressive stress during early stage of chondrogenic
differentiation of rat BMSCs. J Cell Physiol. 228:1935–1942. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Pernet V, Hauswirth WW and Di Polo A:
Extracellular signal-regulated kinase 1/2 mediates survival, but
not axon regeneration, of adult injured central nervous system
neurons in vivo. J Neurochem. 93:72–83. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Shi B, Ding J, Liu Y, Zhuang X, Zhuang X,
Chen X and Fu C: ERK1/2 pathway-mediated differentiation of
IGF-1-transfected spinal cord-derived neural stem cells into
oligodendrocytes. PLoS One. 9:e1060382014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang P, Wu Y, Jiang Z, Jiang L and Fang
B: Osteogenic response of mesenchymal stem cells to continuous
mechanical strain is dependent on ERK1/2-Runx2 signaling. Int J Mol
Med. 29:1083–1089. 2012.PubMed/NCBI
|
|
45
|
Yang SJ, Chang SC, Wen HC, Chen CY, Liao
JF and Chang CH: Plumbagin activates ERK1/2 and Akt via superoxide,
Src and PI3-kinase in 3T3-L1 cells. Eur J Pharmacol. 638:21–28.
2010. View Article : Google Scholar : PubMed/NCBI
|
